HLTHi Review

HLTHi's current footer, terms, and federal NPI record identify Zenith Health Ventures, LLC as the operator behind the HLTHi trade name. The public corporate office is 685 West Lumsden Road in Brandon, Florida. NPPES lists the organization as an active multi-specialty clinic or center, but organizational enumeration does not validate each treating clinician or dispensing pharmacy.

The scope gate includes four service areas: GLP-1 and non-GLP-1 weight management, erectile dysfunction, hair loss, and a limited menopause-related catalog. Mental health, urgent care, sleep, birth control, primary care, and unrelated prescription products remain outside this review even though they appear in the broader store.

The home page says patients always see a real doctor, specifically an MD or DO, and never an NP or PA. Current women's-health copy says prescriptions can be written by MDs, DOs, nurse practitioners, or physician assistants. The terms also contemplate a care team with multiple professional roles. That is a material first-party contradiction, so this review does not promise physician-only care.

The apparent encounter model depends on the pathway. Weight and hair-loss pages describe an online questionnaire and a provider review within 24 to 48 hours. Help content also explains how to join a scheduled live video visit. Patients should confirm whether their selected program uses asynchronous review, synchronous video, or both.

Weight management publishes a $49.99 initial consultation and $74.99 ongoing monthly fee. The pricing page says membership and medicine are charged separately. The first-month consultation is an introductory service component and does not enter the ongoing monthly medication-card averages.

The current Ozempic catalog variant is $249.99 and the current Wegovy variant is $379 for a stated one-month supply. Their unweighted drug-price mean is $314.50. Adding the $74.99 ongoing membership gives $389.49, displayed compactly as Avg. $389/mo ongoing. The card stays comparison-disabled because the brand indications, route metadata, quantity fields, insurance claims, and live-page price relationships conflict.

Mounjaro variants are $279.99, $354.99, $354.99, and $254.99. Zepbound variants are $279.99, $279.99, $279.99, and $374.99. Their eight-price unweighted mean is $307.49; adding ongoing membership gives $382.48, displayed as Avg. $382/mo ongoing. Nonmonotonic dose prices, identical sort positions, MSRP values below sale prices, and a page-level same-price-for-all-doses claim prevent automated comparison.

Rybelsus is listed at $289. Adding ongoing weight membership produces $363.99, shown as $364/mo ongoing. The separate Oral Semaglutide product says it contains semaglutide with metformin but never states the metformin amount or complete formula, so that product remains editorial-only rather than creating another therapy.

Metformin is listed at $49.99 across three strengths. Adding the ongoing weight membership gives $124.98, shown as $125/mo ongoing. The catalog describes metformin as a diabetes medicine; any use in a weight pathway must be an individualized clinician decision and may be off-label for the intended goal.

The ED program data lists a $49 initial consultation and $19 per month. Sildenafil and tadalafil variants are each listed at $49.99. A help article says prescriptions are included in the visit fee or subscription, while the cart and product catalog present separate charges. Both ED cards therefore say Monthly total conflicted and retain the exact figures in their notes.

The hair-loss program data lists a $49.99 initial consultation and $29.99 per month. Finasteride is separately listed at $49.99, while help copy suggests prescription inclusion. Its card also says Monthly total conflicted. Minoxidil appears as solution and foam variants but its description calls it a topical cream while global metadata says oral tablet, so minoxidil stays editorial-only until the actual dosage form can be verified.

Estradiol appears in three variants explicitly named as patches at 0.025 mg, 0.05 mg, and 0.1 mg, each priced at $14.99. Global metadata incorrectly calls the product an oral tablet. No current women's-health program fee, supply duration, quantity, or renewal cadence is exposed, so the card shows $14.99 + $35 visit and remains comparison-disabled.

Progesterone is listed at $14.99 in 100 mg and 200 mg strengths, but quantity, recurrence, and exact dosage form are not reliable enough for a normalized card. The women's-health hub appears to look for a program that is absent from the current public program feed and may display pricing as coming later. Menopause counseling does not establish a complete HRT subscription.

The compounded semaglutide listing says it contains an unspecified B complex, and compounded tirzepatide says it contains vitamin B6. The generic tirzepatide entry does not clearly establish whether it is an approved brand, a compounded product, or another formulation. These incomplete identities stay outside medication matching and price comparison.

HLTHi's pharmacy legal page says all medications dispensed through its services are FDA approved. That cannot describe the live compounded semaglutide and tirzepatide products, because compounded drugs are not FDA approved. FDA also warns that added ingredients such as B vitamins in compounded semaglutide have not established safety or effectiveness for that use.

HLTHi's legal jurisdiction page claims availability in all 50 states and Washington, DC, subject to state restrictions. The current weight, ED, and hair program data lists 49 states and omits Virginia as well as Washington, DC. Current availability must be confirmed before payment rather than inferred from the broader legal statement.

Insurance language is also scope dependent. A general help page describes the platform as self-pay and says HLTHi does not bill insurance. Weight-loss marketing and product badges mention insurance support, and pharmacy help says a dispensing partner may process insurance when applicable. Patients need a written estimate for service fees, medication, and any pharmacy benefit separately.

Laboratory testing is not universally included. HLTHi says a clinician may recommend tests, that specimens are not collected on site, and that the platform does not directly send orders to local labs. Terms generally exclude lab and diagnostic charges unless a checkout page expressly says otherwise.

Prescriptions may be sent to a patient's local pharmacy or coordinated through Photon for pickup or home delivery. Help content says Photon normally contacts a patient within two to four hours after a visit. One weight-loss section says cash-pay medicines ship in one to two days, while another says orders usually arrive in three to five business days. No single delivery promise is defensible.

The formal refund policy makes a consultation nonrefundable once it starts. Ineligibility, identity or location failure, a no-show, nonresponse, false or incomplete information, and missing labs or documents do not create a refund right. Medication cannot be returned after dispensing, and a compound cannot be returned once prepared. Insurance denial, prior-authorization denial, and shortage also do not qualify.

A subscription must be canceled through the patient portal before the next billing cycle. The formal policy says cancellation requests by phone or email are not processed. A charge within the prior 30 days may qualify for a refund only when the patient had no medication access during that period. Damaged or incorrect orders should be reported within 48 hours, but replacement remains discretionary.

Support is published for Monday through Friday, 9am to 5pm Eastern, with an aim to reply within one business day. General support uses support@hlthi.life, and patient help also identifies patients@hlthi.life. These are service targets rather than guarantees and are not emergency channels.

The privacy policy says HLTHi collects account, medical, payment, communication, prescription, pharmacy, device, IP, approximate-location, activity, and cookie data. It describes sharing with providers, pharmacies, processors, service vendors, and regulators and says it does not sell personal data. The scope and legal basis of each disclosure still depend on context.

Awin program 120772 remains pending. The recorded commercial terms are 10% on completed and approved memberships with a 30-day attribution window; one-time visits, labs, and prescriptions are excluded. The network reports an average CPA of $17.57, not an EPC. With no approved tracking URL or customer offer, the CTA remains an ordinary nofollow link, and affiliate economics do not affect the score.